June 4, 2024Presentation - Penser by Carnegie Healthcare Event
March 26, 2024Live-streamed R&D update regarding Paccal Vet
February 26, 2024Presentation - Vivesto - Fokuserat och slimmat för en nystart
November 17, 2023Presentation - Vivesto - Paccal Vet redo för nästa steg
October 26, 2023Interview Erik Penser Bank
August 24, 2023Presentation - EPB Bolagsdag
May 25, 2023Presentation Erik Penser Bank
May 5, 2022Anglonordic Life Science Conference
March 14, 2022Oasmia Pharmaceutical – Aktiedagen Stockholm
January 19, 2022Rights Issue Presentation at Erik Penser Bank
December 2, 2021Presentation at Stora Aktiedagen Stockholm
December 2, 2021Oasmia - Presentation Erik Penser Bank
October 21, 2021Interview Erik Penser Bank
September 29, 2021Naventus LifeScience Summit
September 7, 2021Presentation at Aktiedagen Stockholm
June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical
April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
March 21, 2021BioEurope Spring, Virtual
March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual
March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil
January 19, 2021SEB Digital Healthcare Seminar Presentation
December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference
October 29, 2020BIO-Europe®, Virtual Conference
October 7, 2020Oasmia Erik Penser Cancer Day Presentation
September 24, 2020Oasmia Erik Penser Investor Event Presentation
September 21, 2020Presentation at Sachs Biotech in Europe Forum
September 15, 2020Aktiedagen Digitalt
July 30, 2020Analysguiden: Interview with Oasmia
June 10, 2020Company Presentation Aktiespararna
June 3, 2020Avanza Börsdag
May 13, 2020Strategic Review Presentation
March 25, 2020Elevar deal
February 14, 2020Oasmia appoints new CEO
July 16, 2024Swiss Nordic Bio